C3.ai, Inc. (AI) on the NYSE closed at $9.19 on 06 Mar 2026, down $0.20 or -2.13% on volume 4,733,713 shares. The AI stock has a market cap near $1.26 billion and trades well below its 50-day average of $11.94 and 200-day average of $17.82. Investors are watching federal contract momentum and upcoming fiscal 2026 earnings on 03 Jun 2026 for signs the company can convert large bookings into revenue.

AI stock market close snapshot

C3.ai (AI) closed at $9.19 on the NYSE in the United States with a day low of $9.05 and a day high of $9.32. Trading volume was 4.73 million versus an average volume of 7.01 million, showing muted participation. Year range runs from $7.73 to $30.24, highlighting high historical volatility.

Federal momentum and recent catalysts shaping AI stock

C3.ai reported growing federal, defense and aerospace bookings that rose 134.00% year over year and made up 55.00% of bookings during the quarter. Management cited new awards from the U.S. Department of Agriculture and Department of Energy, and a NATO deal that expands international defense work. These government wins offer a stable revenue channel but do not erase the execution misses noted by management this quarter source.

Financials and valuation for AI stock

C3.ai posts trailing metrics that combine liquidity and losses: EPS -3.16, PE -2.91, cash per share $4.48, and price-to-sales 4.07. Revenue per share is $2.22 and annual revenue growth was 25.27% (FY 2025). The company shows a strong current ratio of 6.58, but negative operating margins and long receivable days of 146.73, which pressure cash conversion.

Technicals and trading dynamics for AI stock

Momentum indicators show a weak profile: RSI 39.56 and MACD at -0.83 with a small histogram. ATR is 0.76 and Bollinger bands span $7.99 to $12.11, highlighting wide movement potential. On-sector action, Technology peers are mixed, and AI stock has underperformed its industry over three months by roughly 22.00%.

Meyka Grade and model forecast for AI stock

Meyka AI rates AI with a score out of 100: 65.27 / 100 | Grade B | Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a monthly target of $5.91 and a yearly target of $1.14, implying downside of -35.70% and -87.56% versus the current price $9.19. Forecasts are model-based projections and not guarantees.

Outlook, risks and price target scenarios for AI stock

Catalyst upside centers on federal contract execution and enterprise deals with cloud partners. Key risks include mounting receivables, negative operating margins, and split analyst sentiment—consensus reads 4 Hold and 4 Sell. We outline scenario price targets in USD: Bear $6.00, Base $10.00, Bull $18.00, each tied to revenue conversion, margin recovery, and renewed commercial traction.

Final Thoughts

C3.ai (AI) closed at $9.19 on 06 Mar 2026 in the United States on the NYSE, a price that reflects both government contract momentum and persistent execution challenges. The AI stock shows clear opportunity in federal and defense pipelines, but earnings execution, long receivable cycles, and negative margins keep risk elevated. Meyka AI’s model projects short-term targets at $5.91 and a one-year figure near $1.14, signaling substantial downside in a stress scenario. Our proprietary grade is 65.27 / 100 (Grade B, HOLD), which balances sector opportunity and weak near-term financials. Watch the 03 Jun 2026 earnings release closely; that report must show improving bookings-to-revenue conversion, margin stabilization, or clearer guidance to shift the outlook. These views are market analysis, not investment advice, and forecasts are model-based projections and not guarantees. Meyka AI is an AI-powered market analysis platform providing this data-driven context for investors.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.